KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Equity Ratio (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Equity Ratio for 7 consecutive years, with 0.61 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 23.23% year-over-year to 0.61, compared with a TTM value of 0.61 through Sep 2025, down 23.23%, and an annual FY2024 reading of 0.59, up 17.05% over the prior year.
  • Equity Ratio was 0.61 for Q3 2025 at Clover Health Investments, up from 0.6 in the prior quarter.
  • Across five years, Equity Ratio topped out at 1.01 in Q4 2022 and bottomed at 0.18 in Q1 2022.
  • Average Equity Ratio over 5 years is 0.52, with a median of 0.57 recorded in 2021.
  • The sharpest move saw Equity Ratio surged 173.5% in 2021, then tumbled 73.07% in 2022.
  • Year by year, Equity Ratio stood at 0.57 in 2021, then soared by 77.12% to 1.01 in 2022, then plummeted by 50.12% to 0.5 in 2023, then rose by 17.05% to 0.59 in 2024, then grew by 3.7% to 0.61 in 2025.
  • Business Quant data shows Equity Ratio for CLOV at 0.61 in Q3 2025, 0.6 in Q2 2025, and 0.58 in Q1 2025.